Reglory
EYES
Polynucleotides, niacinamide and botulinum polypeptide in one syringe.
€28VAT and European delivery included
1 x 1.1 ml syringe
For trained practitioners, clinics and authorised distributors. Confirmation is required at checkout.
What it is
Reglory EYES
Reglory Eyes is a polynucleotide-based solution designed to target fine lines and enhance overall skin rejuvenation, particularly in facial areas. It reduces the appearance of dark circles, diminishes signs of fatigue and refreshes the skin.
The formula contains niacinamide and botulinum polypeptide, which help refine pores, even out skin tone and visibly reduce the appearance of wrinkles.
Composition
- Polynucleotide
- 2 mg / ml
- Niacinamide
- 3 mg / ml
- Oligopeptide-91 · Clostridium Botulinum Polypeptide-1
- —
Polynucleotides, niacinamide and botulinum polypeptide in one syringe.
How it works
Three things it does first
Deep hydration and long-lasting moisture retention
Skin repair and renewal through accelerated cell turnover
Even skin tone
greater skin thickness and density
The full list of effects, the areas of application and the protocol are below. All of it is reproduced from the manufacturer's catalogue for this product.
Benefits & effects
What it addresses
- Deep hydration and long-lasting moisture retention
- Skin repair and renewal through accelerated cell turnover
- Even skin tone — greater skin thickness and density
- Pore tightening by reinforcing skin structure
- Enhanced elasticity through elastin production
Areas of application: Around the eyes · Face · Neck · Back of hands
Presentation & protocol
- Presentation
- 1 × 1.1 ml pre-filled syringe
- Indication
- Superficial layer or epidermis / dermis
- Needle
- 32G × 4 mm. Needles are not included
- Treatment interval
- 3 sessions, 4 weeks apart; repeat twice a year
- Duration
- Over 3 months
- Shelf life
- 36 months from the date of manufacture
Method
How it is used
- 1 Disinfect
- Thoroughly disinfect the treatment area before the procedure.
- 2 Anaesthetise
- Apply topical anaesthesia if necessary.
- 3 Prepare
- Insert a 32G × 4 mm needle into the syringe. Needles are not included.
- 4 Inject
- Inject the predetermined amount according to the practitioner's judgement.
Safe use
Seven instructions
- Inspect
- the product and packaging for any damage or deformation.
- Check
- the syringe content and dosage after opening the package.
- Select
- a sterile needle suitable for the injection site and connect it properly.
- Avoid
- injection into blood vessels to prevent tissue necrosis.
- Massage
- the injection site gently during and after the procedure.
- Explain
- all indications, contraindications and side effects to the patient beforehand.
- Use
- only by trained medical professionals familiar with injection techniques.
Before, after, and who it is not for
Guidance & contraindications
Before the treatment
- No chemical peels or strong cosmetics for several days before the treatment.
- No alcohol for at least 48 hours before the treatment.
- No excessive heat exposure — solarium, sauna or direct sun.
After the treatment
- No sun or heat for 4 days; use SPF 50.
- No intense exercise, sauna, swimming pool or crowded places for 7 days.
- No peels or strong cosmetics for several days.
- No alcohol for 24 hours and no make-up for 48 hours.
- Strict hygiene — single-use towels, clean brushes, fresh bed linen.
Possible side effects
- Mild swelling at the injection site
- Slight redness and minor injection marks
- Mild bruising
- Erythema, itching or irritation
- Possible allergic reactions to the products used in the treatment
Contraindications
- Under 18 years of age
- Pregnancy or breastfeeding
- Allergy to the product ingredients or to hyaluronic acid
- Skin infection — bacterial, fungal or viral — inflammation or active herpes
- Severe acne requiring medical treatment
- Coagulation disorders or anticoagulant therapy
- High allergic susceptibility, skin allergies, irritated or damaged skin
- Connective tissue disease, hypertrophic scarring or keloid tendency
- Autoimmune disease, cancer, or ongoing chemotherapy or radiotherapy
- Immunosuppressants, corticosteroids in the last 6–8 weeks, or retinoids in the last 6 months
- Recent surgery (2 months) or cryotherapy (6 months)
- Multiple naevi, extensive telangiectasia or psoriasis
- Severe psychiatric disorders affecting cooperation with the treatment
Treatment protocols may vary depending on the practitioner's clinical experience and treatment environment. This material is provided as a guideline to support safe and effective procedures. This product should only be used by trained professionals or doctors.